Advertisement

Advertisement

IPSC Stock Latest News

Century Therapeutics presents new preclinical data for CNTY-813

The FlyCentury Therapeutics presents new preclinical data for CNTY-813

Century Therapeutics Advances CNTY-813 Diabetes Cell Therapy

PremiumCompany Announcements

Century Therapeutics Advances CNTY-813 Diabetes Cell Therapy

2d ago

Century Therapeutics initiated with an Outperform at Mizuho

PremiumThe Fly

Century Therapeutics initiated with an Outperform at Mizuho

14d ago

Century Therapeutics reports Q1 EPS (11c), consensus (17c)

PremiumThe Fly

Century Therapeutics reports Q1 EPS (11c), consensus (17c)

28d ago

Century Therapeutics price target raised to $5 from $2 at H.C. Wainwright

PremiumThe Fly

Century Therapeutics price target raised to $5 from $2 at H.C. Wainwright

2M ago

Century Therapeutics Updates ATM Program to Enhance Liquidity

PremiumCompany AnnouncementsCentury Therapeutics Updates ATM Program to Enhance Liquidity

3M ago

Century Therapeutics Reports 2025 Results and Pipeline Progress

Company Announcements

Century Therapeutics Reports 2025 Results and Pipeline Progress

3M ago

Century Therapeutics reports FY25 EPS (14c), consensus (17c)

The Fly

Century Therapeutics reports FY25 EPS (14c), consensus (17c)

3M ago

IPSC Upcoming Earnings Report: What to Expect?

PremiumPre-Earnings

IPSC Upcoming Earnings Report: What to Expect?

3M ago

Century Therapeutics initiated with a Buy at TD Cowen

PremiumThe Fly

Century Therapeutics initiated with a Buy at TD Cowen

4M ago

Century Therapeutics files to sell 176.09M shares of common stock for holders

PremiumThe Fly

Century Therapeutics files to sell 176.09M shares of common stock for holders

4M ago

Century Therapeutics Regains Nasdaq Compliance, Halts Reverse Split

PremiumCompany Announcements

Century Therapeutics Regains Nasdaq Compliance, Halts Reverse Split

5M ago

Century Therapeutics price target raised to $4 from $2 at Piper Sandler

PremiumThe FlyCentury Therapeutics price target raised to $4 from $2 at Piper Sandler

5M ago

Century Therapeutics Highlights Progress in Immune-Evasive Cell Therapies

Company Announcements

Century Therapeutics Highlights Progress in Immune-Evasive Cell Therapies

5M ago

Century Therapeutics price target lowered to $6.60 from $8 at Clear Street

The Fly

Century Therapeutics price target lowered to $6.60 from $8 at Clear Street

5M ago

Century Therapeutics Announces Oversubscribed $135 Million Financing

PremiumCompany Announcements

Century Therapeutics Announces Oversubscribed $135 Million Financing

5M ago

Century Therapeutics prices 117.4M shares at $1.15 in private placement

PremiumThe Fly

Century Therapeutics prices 117.4M shares at $1.15 in private placement

5M ago

Century Therapeutics announces resignation of board member

PremiumCompany Announcements

Century Therapeutics announces resignation of board member

5M ago

Century Therapeutics Updates on Cell Therapy Advancements

PremiumCompany Announcements

Century Therapeutics Updates on Cell Therapy Advancements

6M ago

Century Therapeutics Expands Board with New Appointments

PremiumCompany AnnouncementsCentury Therapeutics Expands Board with New Appointments

6M ago

Century Therapeutics appoints Lee, Murphy to board of directors

The Fly

Century Therapeutics appoints Lee, Murphy to board of directors

6M ago

Century Therapeutics downgraded to Market Perform from Outperform at Leerink

The Fly

Century Therapeutics downgraded to Market Perform from Outperform at Leerink

7M ago

Trending

S&P 500

―

Dow Jones

―

Nasdaq 100

―

More Trending Stocks >